NDC 72934-1169

PENTOXIFYLLINE 0.5% / TRIAMCINOLONE ACETONIDE 0.1%

Pentoxifylline 0.5% / Triamcinolone Acetonide 0.1%

PENTOXIFYLLINE 0.5% / TRIAMCINOLONE ACETONIDE 0.1% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Pentoxifylline; Triamcinolone Acetonide.

Product ID72934-1169_88dee26d-be0a-5ae2-e053-2995a90ac52c
NDC72934-1169
Product TypeHuman Prescription Drug
Proprietary NamePENTOXIFYLLINE 0.5% / TRIAMCINOLONE ACETONIDE 0.1%
Generic NamePentoxifylline 0.5% / Triamcinolone Acetonide 0.1%
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2019-05-15
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NamePENTOXIFYLLINE; TRIAMCINOLONE ACETONIDE
Active Ingredient Strength1 g/100g; g/100g
Pharm ClassesBlood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-1169-2

30 g in 1 BOTTLE, PUMP (72934-1169-2)
Marketing Start Date2019-05-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-1169-2 [72934116902]

PENTOXIFYLLINE 0.5% / TRIAMCINOLONE ACETONIDE 0.1% GEL
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-15

Drug Details

Active Ingredients

IngredientStrength
PENTOXIFYLLINE.5 g/100g

OpenFDA Data

SPL SET ID:88dee26d-be09-5ae2-e053-2995a90ac52c
Manufacturer
UNII

Pharmacological Class

  • Blood Viscosity Reducer [EPC]
  • Hematologic Activity Alteration [PE]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Blood Viscosity Reducer [EPC]
  • Hematologic Activity Alteration [PE]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.